Delivery Order SPE2DB22D3301-SPE2DB24FX8RN
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order to supply Revlimid 10 mg capsules, a specialty pharmaceutical product, with a potential value of $27,859.78. The contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp, through its Corporate...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $177,862.20 order is for the supply of REVLIMID 5 mg capsules, a prescription medication. The order was not set aside for any specific business type. Amerisourcebergen Drug Corp has an extensive history of providing pharmaceutical products and medical supplies to support U.S....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of REVLIMID 10 MG Capsules. The award has a ceiling value of $105,612.88 and an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $238,206.60 firm fixed price award is for the supply of REVLIMID 10 mg capsules. No set-aside designation was used. Amerisourcebergen Drug Corp has an extensive history of providing pharmaceutical and medical supply products and distribution services to the Department...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, worth $20,562.98, is for the delivery of REVLIMID 25 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $37,445.14 delivery order contract is for the supply of REVLIMID 25 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024 and utilizes a Firm Fixed Price pricing type. There is no set-aside used for this award. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $101,816.34 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REVLIMID 15 MG CAPSULE 100S. This delivery order was not set aside and is part of a larger contract the company holds with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, with a potential value of $750,000...
- This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $193,390.93 firm fixed price contract is for the supply of Revlimid 5 mg capsules. Amerisourcebergen has an established history of providing pharmaceutical and medical supply products and services to DLA Troop Support Medical facilities. This award did not utilize a set-aside designation. The performance location is Amerisourcebergen's corporate...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $18,722.57 firm fixed-price contract is for the supply of REVLIMID 25 MG CAPSULE 21S medication, with a period of performance ending on August 6, 2024. Amerisourcebergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies to...
- Amerisourcebergen Drug Corp has received a $56,490.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply REVLIMID 10 MG CAPSULE 28S pharmaceutical products. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified medications to DLA Troop Support Medical facilities in support of military treatment programs. This delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp's...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX8RNDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,281.49 firm fixed price delivery order is for the provision of REVLIMID 25 MG CAPSULE 21S pharmaceutical products. The contract has no set-aside designation and the performance location is Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is an experienced prime contractor providing a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical programs. The company also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 1/12/24 |